Vallerie McLaughlin (@valmclaughlinmd) 's Twitter Profile
Vallerie McLaughlin

@valmclaughlinmd

Cardiologist specializing in pulmonary hypertension at the University of Michigan, Loving mother, #PAH #CTEPH @umichmedicine @umichcvc

ID: 1638311904094347271

calendar_today21-03-2023 22:55:55

30 Tweet

203 Followers

42 Following

Team PHenomenal Hope (@teamphhope) 's Twitter Profile Photo

The FDA has approved two new therapies for the treatment of #pulmonaryhypertension, Opsynvi and Winrevair. Learn the basics about pathways, side effects, and if this treatment could be a fit for you in our pre-recorded webinar. bit.ly/4bz73rF

Team PHenomenal Hope (@teamphhope) 's Twitter Profile Photo

We're going to Barcelona! We look forward to bringing together experts in the science of PH, patients, caregivers, and all to our first ever global fun walk, the Let Me Be Your Lungs Unity Walk. Learn more at bit.ly/3RayakZ

We're going to Barcelona! We look forward to bringing together experts in the science of PH, patients, caregivers, and all to our first ever global fun walk, the Let Me Be Your Lungs Unity Walk. Learn more at bit.ly/3RayakZ
ATS Blue Journal (@atsblueeditor) 's Twitter Profile Photo

Thanks to Sandeep Sahay, MD, MSc, ATSF, for his contribution to the September 1 issue Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective Sandeep Sahay, MD, MSc Vallerie McLaughlin atsjournals.org/doi/full/10.11…

Thanks to Sandeep Sahay, MD, MSc, ATSF, for his contribution to the September 1 issue
 
Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective
<a href="/SandeepSahayMD/">Sandeep Sahay, MD, MSc</a> 
<a href="/ValMcLaughlinMD/">Vallerie McLaughlin</a> 

atsjournals.org/doi/full/10.11…
Victor M. Moles (@victor_moles) 's Twitter Profile Photo

Wow! Great news for the #PAH community! The #ZENITH clinical trial meets primary endpoint at interim analysis and adds data supporting the use of #sotatercept. An immense honor to be part of this team. Vallerie McLaughlin U-M Health Frankel CVC Michigan Medicine

Wow! Great news for the #PAH community! The #ZENITH clinical trial meets primary endpoint at interim analysis and adds data supporting the use of #sotatercept. An immense honor to be part of this team. <a href="/ValMcLaughlinMD/">Vallerie McLaughlin</a> <a href="/umichCVC/">U-M Health Frankel CVC</a> <a href="/umichmedicine/">Michigan Medicine</a>
Marcin Kurzyna (@marcin_kurzyna) 's Twitter Profile Photo

Full room packed at joint session of European Society of Cardiology and ERS on modern management of pulmonary hypertension. Sotatercept, seralutynib, precision medicine and pulmonary artery denervation are currently hot topics in the field #ESCCongress #PulmonaryHypertension Vallerie McLaughlin

Full room packed at joint session of <a href="/escardio/">European Society of Cardiology</a> and <a href="/EuroRespSoc/">ERS</a> on modern management of pulmonary hypertension. Sotatercept, seralutynib, precision medicine and pulmonary artery denervation are currently hot topics in the field
#ESCCongress #PulmonaryHypertension <a href="/ValMcLaughlinMD/">Vallerie McLaughlin</a>
U-M Health Frankel CVC (@umichcvc) 's Twitter Profile Photo

Prescribing sotatercept alongside standard treatment for pulmonary arterial hypertension significantly reduces the likelihood of worsening disease when added within the first year after diagnosis, according to a new study in NEJM led by Vallerie McLaughlin: michiganmedicine.org/health-lab/bio…